CAS 105816-04-4
:Nateglinide
- AY 4166
- N-[[trans-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine
- D-Phenylalanine, N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-
- D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, trans-
- A 4166
- Prezzo più basso
- Prezzo più alto
- Purezza più bassa
- Purezza più alta
- Consegna più veloce
Nateglinide
CAS:Formula:C19H27NO3Purezza:>98.0%(HPLC)(T)Colore e forma:White to Almost white powder to crystalPeso molecolare:317.43NATEGLINIDE CRS
CAS:NATEGLINIDE CRSFormula:C19H27NO3Colore e forma:White. Powder.Peso molecolare:317.4226Nateglinide
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof, nesoiFormula:C19H27NO3Colore e forma:White PowderPeso molecolare:317.19909Nateglinide
CAS:Formula:C19H27NO3Purezza:≥ 98.0%Colore e forma:White to off-white powderPeso molecolare:317.42Nateglinide (Standard)
CAS:Nateglinide (Standard) is a reference standard of Nateglinide intended for quantitative analysis, quality control, and related biochemical research applications.Formula:C19H27NO3Peso molecolare:317.4226Nateglinide
CAS:Prodotto controllatoApplications An amino-acid derivative that stimulates insulin secretion. Used as an antidiabetic.
References Shinkai, H., et al.: J. Med. Chem., 32, 1436 (1989), Sato, Y., et al.: Diabetes Res. Clin. Pract., 12, 53 (1991), Vicent, D., et al.: J. Clin. Invest., 111, 1373 (2003), Ceriello, A., et al.: Diabet. Med., 21, 171 (2004),Formula:C19H27NO3Colore e forma:NeatPeso molecolare:317.42Nateglinide
CAS:(R)-2-rel-((1r,4R)-4-Isopropylcyclohexanecarboxamido)-3-phenylpropanoic acidFormula:C19H27NO3Purezza:99%Peso molecolare:317.42Nateglinide
CAS:Nateglinide is an oral drug for type 2 diabetes, stimulating insulin release; may cause rare acute liver injury.Formula:C19H27NO3Purezza:99.93% - 99.94%Colore e forma:SolidPeso molecolare:317.4226Nateglinide - Bio-X ™
CAS:Nateglinide is used to treat type 2 diabetes mellitus as an oral hypoglycemic, insulinotropic agent. It is a blocker of ATP-dependent potassium channels and works by increasing the body's production of insulin, which lowers blood glucose levels. Nateglinide has been shown to be effective in reducing postprandial blood glucose levels in patients with type 2 diabetes who have not responded well to other treatments. The effects of nateglinide are reversible.Formula:C19H27NO3Purezza:Min. 95%Peso molecolare:317.42 g/molNateglinide
CAS:Nateglinide is used to treat type 2 diabetes mellitus as an oral hypoglycemic, insulinotropic agent. It is a blocker of ATP-dependent potassium channels and works by increasing the body's production of insulin, which lowers blood glucose levels. Nateglinide has been shown to be effective in reducing postprandial blood glucose levels in patients with type 2 diabetes who have not responded well to other treatments. The effects of nateglinide are reversible.
Formula:C19H27NO3Purezza:Min. 95%Colore e forma:PowderPeso molecolare:317.42 g/mol















